Tekmira reports on protection against deadly Ebola virus

Tekmira Pharmaceuticals (TSX:TKM) has published a series of studies in The Lancet demonstrating the ability of an RNA-interference therapeutic using Tekmira’s SNALP lipid nanoparticle delivery technology to protect non-human primates from Ebola virus, a highly contagious and lethal human infectious disease. “These very striking data are the first demonstration that RNAi is efficacious in an [...]

RBC ups QLT to “outperform”

Calling QLT’s litigation settlement with Massachusetts General Hospital over Visudyne royalties “better than we had anticipated,” RBC Capital Markets upgraded QLT to “outperform” from “sector perform” and raised its target price to $6 (U.S.) from $4.50. The stock (NASDAQ: QLTI; TSX: QLT) finished trading at $4.50 on Wednesday. Analyst Doug Miehm writes that at the [...]